来氟米特对顽固性局灶节段性肾小球硬化肾病综合征患者的疗效评估

2014-06-30 18:34:07魏新平
医药与保健 2014年7期
关键词:疗效

魏新平

【摘 要】 目的评估来氟米特对顽固性局灶节段性肾小球硬化肾病综合征患者的临床治疗效果。方法选取40例顽固性局灶节段性肾小球硬化肾病综合征患者,随机分为对照组和观察组,各20例。在常规治疗基础上,对照组给予环孢素A口服,观察组给予来氟米特口服,观察两组各项指标水平、治疗效果及不良反应发生情况。结果观察组24 h尿蛋白定量、血清白蛋白和血胆固醇改善情况均优于对照组,差异均具有统计学意义(P<0.05)。观察组治疗效果明显优于对照组(P<0.05)。两组不良反应发生率差异无统计学意义(P>0.05)。结论来氟米特对顽固性局灶节段性肾小球硬化肾病综合征患者可明显改善肾功能,效果较好,安全性高。

【关键词】 来氟米特;局灶节段性肾小球硬化;肾病综合征;疗效

【中图分类号】 R692.6【文献标识码】 A

Efficacy of Leflunomide in Patients with Refractory Nephrotic Syndrome Due to Focal Segmental Glomurular Sclerosis

Wei Xinping

(Department of Rheumatology and Nephropathy,the First people's Hospital of Shangqiu,476100)

【Abstract】 ObjectiveTo evaluate the efficacy of leflunomide in patients with refractory nephrotic syndrome due to focal segmental glomurular sclerosis.Methods40 patients with refractory nephrotic syndrome due to focal segmental glomurular sclerosis were selected and randomly divided into control group and observation group,20 cases in each group.On the basis of routine treatment,the control group was treated with ciclosporin A,the observation group was treated with leflunomide.The level of every index,therapeutic effects, adverse reactions in two groups were compared.Results24 h urinary protein,serum albumin and blood cholesterol in observation group were better than control group,the differences were statistically significant(P<0.05).The therapeutic effects in observation group were better than control group(P<0.05). The differences of incidences of adverse reaction between two groups were not statistically significant(P>0.05).ConclusionLeflunomide could significantly improve renal function of patients with refractory nephrotic syndrome due to focal segmental glomurular sclerosis,had good therapeutic effects and high safety.

【Keywords】 leflunomide;focal segmental glomurular sclerosis; nephrotic syndrome;therapeutic effect

局灶节段性肾小球硬化是肾病综合征常见病理类型。难治性肾病综合征(RNS)是肾脏病领域的难点问题,是指经过正规激素疗程治疗无效或撤药困难或反复发作[1]。顽固性局灶节段性腎小球硬化肾病综合征临床治疗效果较差,常用的细胞毒性药物包括环磷酰胺、环孢素A和硫唑嘌呤,不良反应多,可致骨髓抑制、肝肾损害等。来氟米特(LEF)是一种新型免疫抑制剂,通过影响细胞嘧啶代谢起到免疫调节作用,安全性高。商丘市第一人民医院采用来氟米特治疗顽固性局灶节段性肾小球硬化肾病综合征患者,效果较好,现总结如下。

1资料与方法

1.1一般资料选取商丘市第一人民医院2011年3月至2012年9月收治的难治性肾病综合征患者40例,均符合肾病综合征的诊断标准[2];……

登录APP查看全文

猜你喜欢
疗效
止眩汤改良方治疗痰瘀阻窍型眩晕的临床疗效观察
冷喷联合湿敷甘芩液治疗日晒疮的短期疗效观察
中西医结合治疗慢性盆腔炎的疗效观察
回药失荅剌知丸治疗中风后痴呆的疗效观察
蒙医药治疗无症状型心肌缺血疗效观察
中西医结合治疗乳痈的疗效观察
脐灸治疗脑卒中后便秘的疗效
旋转DSA指导下介入治疗脑动脉瘤的疗效观察
破裂腹主动脉瘤的腔内修复术与开放手术疗效比较
止嗽散联合阿斯美治疗感染后咳嗽疗效观察